Kala Pharmaceuticals, Inc.
KALA · NASDAQ
Bulios Fair Price
$0.81
49.8% upside
Trenutna cena
$0.54
Po podatkih Bulios Fair Price je delnica KALA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Kala Pharmaceuticals, Inc. (Ticker: KALA) is a biotechnology company focused on the research and development of ophthalmic drugs. The company emphasizes innovative therapeutic approaches to eye diseases through its unique nanotechnology-based approach. Kala Pharmaceuticals is developing drugs designed to provide sustained release of therapeutic agents, which may improve the efficacy and convenience for patients. The company's focus includes indications such as dry eye disease and ocular surface inflammation. With the increasing awareness of the need for treating eye conditions, Kala Pharmaceuticals is well-positioned in the market and may offer an investment opportunity for those interested in the advancements of drugs and technologies in ophthalmology.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Avi Minkowitz
Employees
6
Headquarters
Arlington
Prihajajoči dogodki
Earnings
Upcoming earnings report